Daejeon, South Korea

Shin-Jung Choi

USPTO Granted Patents = 1 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Shin-Jung Choi**

Introduction

Shin-Jung Choi, a prominent inventor based in Daejeon, South Korea, has made significant contributions to the field of biotechnology. With a medical focus on cancer treatment and diagnosis, he has developed innovative solutions that leverage genetic research. His pioneering work is underscored by the patent he holds, reflecting his commitment to enhancing cancer care.

Latest Patents

Choi is the inventor of a patent titled "Use of FLJ25416 Gene." This innovative patent describes a composition for diagnosing cancer and screening anticancer drugs that incorporates the FLJ25416 gene or an antibody directed against the protein expressed by this gene. The invention also includes a treatment composition that involves an inhibitor of the gene or its protein and a pharmaceutically acceptable carrier. This groundbreaking research indicates that the FLJ25416 gene shows high expression in specific cancer cells and enhances the proliferation rate of normal cells. Suppressing its expression results in an inhibitory effect on cancer cell growth, thereby making the gene a valuable target for both cancer diagnosis and treatment.

Career Highlights

Shin-Jung Choi has had a notable career featuring associations with distinguished institutions in the field of biotechnology. He has worked at the Korea Research Institute of Bioscience and Biotechnology, where he contributed to various research initiatives. Additionally, he was involved with St Pharm Co., Ltd., collaborating on projects aimed at advancing medical solutions.

Collaborations

Throughout his career, Choi has collaborated with talented coworkers, including Misun Won and Kyung-Sook Chung. These partnerships have fostered a rich exchange of ideas and insights that enhance the innovation process and lead to significant advancements in their field.

Conclusion

Shin-Jung Choi's innovative work on the FLJ25416 gene represents a significant advancement in cancer diagnosis and treatment. His contributions highlight the potential of genetic research in overcoming medical challenges. As his career progresses, Choi's inventions are likely to continue paving the way for improved healthcare solutions, exemplifying the importance of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…